Sergi, Daniele
 Distribuzione geografica
Continente #
NA - Nord America 900
EU - Europa 513
AS - Asia 128
AF - Africa 2
Totale 1.543
Nazione #
US - Stati Uniti d'America 900
PL - Polonia 389
CN - Cina 48
SE - Svezia 44
SG - Singapore 26
GB - Regno Unito 17
VN - Vietnam 17
IE - Irlanda 16
IN - India 15
ID - Indonesia 11
DE - Germania 10
RU - Federazione Russa 9
FI - Finlandia 8
IT - Italia 7
TR - Turchia 5
FR - Francia 3
JP - Giappone 3
AT - Austria 2
CI - Costa d'Avorio 2
HK - Hong Kong 2
RO - Romania 2
UA - Ucraina 2
BG - Bulgaria 1
IL - Israele 1
LI - Liechtenstein 1
LT - Lituania 1
NL - Olanda 1
Totale 1.543
Città #
Warsaw 389
Fairfield 180
Ashburn 80
Seattle 76
Chandler 74
Woodbridge 74
Houston 67
Wilmington 61
Cambridge 50
Redmond 37
Ann Arbor 26
Singapore 19
Dong Ket 17
Dublin 16
Nanjing 15
Dearborn 12
Jakarta 11
Jacksonville 10
Princeton 10
San Mateo 9
Helsinki 8
London 8
Boston 7
Nanchang 7
New York 6
San Diego 6
Phoenix 5
Beijing 4
Falkenstein 4
Hebei 4
Moscow 4
Redwood City 4
Gurgaon 3
Izmir 3
Rome 3
Abidjan 2
Frankfurt am Main 2
Hong Kong 2
Kocaeli 2
Norwalk 2
Paris 2
Santa Clara 2
Tianjin 2
Vienna 2
Amsterdam 1
Anyang 1
Bristol 1
Cattolica 1
Chicago 1
Chiswick 1
Council Bluffs 1
Edinburgh 1
Hengshui 1
Jiaxing 1
Las Vegas 1
Lavis 1
Marseille 1
Mountain View 1
New Bedfont 1
Orange 1
Prescot 1
San Francisco 1
Seacroft 1
Shanghai 1
Shenyang 1
Sofia 1
Southend 1
Southwark 1
Stockholm 1
Tel Aviv 1
Vaduz 1
Totale 1.354
Nome #
Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer 298
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real- world experience 273
Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies 233
Role of gonadotropin-releasing hormone analogues in metastatic male breast cancer: results from a pooled analysis 222
Efficacy of chemotherapy in metastatic male breast cancer patients: a retrospective study 216
“Triple positive” early breast cancer: an observational multicenter retrospective analysis of outcome 120
The Hippo transducer TAZ as a biomarker of pathological complete response in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy 64
Androgen receptor and antiandrogen therapy in male breast cancer 55
Aromatase inhibitors for metastatic male breast cancer: molecular, endocrine, and clinical considerations 41
Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case series 33
Totale 1.555
Categoria #
all - tutte 4.931
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.931


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020202 0 0 0 0 0 0 55 29 45 13 47 13
2020/2021273 20 27 19 16 45 26 31 8 21 25 13 22
2021/2022101 18 12 6 0 9 2 4 12 5 7 12 14
2022/2023191 24 28 13 24 12 23 3 19 32 2 8 3
2023/202487 4 31 1 4 2 6 5 12 0 0 15 7
2024/202555 7 1 13 9 13 12 0 0 0 0 0 0
Totale 1.555